Breaking News Instant updates and real-time market news.

NAK

Northern Dynasty

$1.84

0.04 (2.22%)

, PBR

Petrobras

$10.08

0.08 (0.80%)

08:45
09/15/17
09/15
08:45
09/15/17
08:45

Largest borrow rate increases among liquid names

Latest data shows the largest indicative borrow rate increases among liquid option names include: Northern Dynasty (NAK) 21.77% +1.36, Petrobras (PBR) 0.96% +0.40, ProShares Ultra DJ UBS Crude Oil (UCO) 2.63% +0.03, Nutanix (NTNX) 1.91% +0.02, Market Vectors Semiconductor (SMH) 1.42% +0.01, ProShares Short VIX Short Term Futures (SVXY) 1.94% +0.01, and MannKind (MNKD) 93.08% +0.01.

NAK

Northern Dynasty

$1.84

0.04 (2.22%)

PBR

Petrobras

$10.08

0.08 (0.80%)

UCO

Universal Compression

$16.88

0.21 (1.26%)

NTNX

Nutanix

$21.61

0.12 (0.56%)

SMH

Market Vectors Semiconductor

$89.90

0.39 (0.44%)

SVXY

ProShares Short VIX Short-Term Futures

$84.46

-1.16 (-1.35%)

MNKD

MannKind

$2.25

0.03 (1.35%)

  • 25

    Sep

NAK Northern Dynasty
$1.84

0.04 (2.22%)

08/28/17
BMOC
08/28/17
INITIATION
BMOC
Market Perform
Northern Dynasty initiated with a Market Perform at BMO Capital
02/16/17
TDSI
02/16/17
UPGRADE
TDSI
Speculative Buy
Northern Dynasty upgraded to Speculative Buy from Hold at TD Securities
PBR Petrobras
$10.08

0.08 (0.80%)

03/22/17
03/22/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. KeyBanc analyst Todd Thomas upgraded Urban Outfitters (URBN) to Overweight from Sector Weight, saying the retailer has a highly differentiated product offering and has made significant investments to capture e-commerce share. 2. Deutsche Bank analyst Rod Lache upgraded BorgWarner (BWA) to Buy from Hold, saying the prospects for business units focused on Internal Combustion efficiency and emissions are better than he previously thought. The analyst expects penetration of battery electric vehicles will remain "relatively low" through the 2020s. He raised his price target for BorgWarner shares to $51 from $41. The analyst this morning also raised his price target for Buy-rated Delphi (DLPH) to $99 from $88 and Hold-rated Tenneco (TEN) to $78 from $75. 3. UBS analyst Julien Dumoulin-Smith upgraded Sunrun (RUN) to Buy from Neutral, citing accelerating prospects amid policy support in the Northeast. 4. Wedbush analyst Henry Coffey upgraded LendingClub (LC) to Neutral from Underperform, saying management has made a very good case in recent meetings on how they will enhance the breadth of the marketplace and grow volumes. 5. Credit Suisse analyst Andre Natal upgraded Petrobras (PBR) to Outperform with an $11 price target saying recent share weakness provides a buying opportunity. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
03/24/17
SOCG
03/24/17
UPGRADE
SOCG
Buy
Petrobras upgraded to Buy from Hold at Societe Generale
Societe Generale upgraded Petrobras to Buy with a $11.50 price target saying the company has lowered capex and controllable costs and will be increasing production growth in 2017.
03/28/17
HSBC
03/28/17
UPGRADE
HSBC
Buy
Petrobras upgraded to Buy from Hold at HSBC
HSBC analyst Lily Yang upgraded Petrobras to Buy with an $11.50 price target.
09/01/17
DBAB
09/01/17
UPGRADE
DBAB
Hold
Petrobras upgraded to Hold from Sell at Deutsche Bank
UCO Universal Compression
$16.88

0.21 (1.26%)

NTNX Nutanix
$21.61

0.12 (0.56%)

09/05/17
KEYB
09/05/17
NO CHANGE
Target $32
KEYB
Overweight
Nutanix head of sales for Americas no longer with company, says KeyBanc
KeyBanc analyst Alex Kurtz said industry contacts indicate Craig Bumpus, Nutanix's Senior Vice President Americas Sales and Global Accounts is no longer with the company. Kurtz believes Nutanix decided to move in a new direction, but notes Mr. Bumpus was largely responsible for North America, which had strong Q4 sales and was performing well into the second half of 2017. The analyst expects Nutanix to pursue a new person for the roll and notes the company has strong sales leadership under Sudheesh Nair. Kurtz rates Nutanix an Overweight with a $32 price target.
09/01/17
PIPR
09/01/17
NO CHANGE
Target $28
PIPR
Overweight
Nutanix target raised to $28 on competitive advantage at Piper Jaffray
Piper Jaffray analyst Andrew Nowinski says a record number of large deals and the increasing penetration of the G2000 allowed Nutanix to exceeded guidance and consensus for the second consecutive quarter. The analyst believes the company has a strong competitive advantage and upped his price target for the shares to $28 from $27. He reiterates an Overweight rating on the name.
08/17/17
JEFF
08/17/17
INITIATION
Target $30
JEFF
Buy
Nutanix initiated with a Buy at Jefferies
Jefferies analyst James Kisner started Nutanix with a Buy rating and $30 price target. After examining the company's recurring software content, the analyst believes the shares are undervalued. He sees the potential for the stock to "nearly double" in an upside case.
08/17/17
08/17/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Medifast (MED) initiated with a Buy at DA Davidson. 2. IEC Electronics (IEC) initiated with a Buy at Maxim. 3. PRA Health (PRAH) initiated with an Outperform at Raymond James. 4. Nutanix (NTNX) initiated with a Buy at Jefferies. 5. El Paso Electric (EE) initiated with a Neutral at Mizuho. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
SMH Market Vectors Semiconductor
$89.90

0.39 (0.44%)

SVXY ProShares Short VIX Short-Term Futures
$84.46

-1.16 (-1.35%)

MNKD MannKind
$2.25

0.03 (1.35%)

08/11/17
MAXM
08/11/17
INITIATION
Target $4
MAXM
Buy
MannKind initiated with a Buy at Maxim
Maxim analyst Jason Kolbert started MannKind with a Buy rating and $4 price target, stating that the relaunch of Afrezza is building traction. A "conservative" 5% share of the U.S. insulin market is a $350M opportunity for Afrezza, added Kolbert.
05/11/17
PIPR
05/11/17
NO CHANGE
Target $0.54
PIPR
Underweight
MannKind sales of Afrezza remain slow, says Piper Jaffray
Piper Jaffray analyst Joshua Schimmer says sales of MannKind's Afrezza "failed to meaningfully inflect" in Q1 despite new commercialization initiatives. The company continues to drain its cash, Schimmer tells investors in a post-earnings research note. He reiterates an Underweight rating on MannKind with a 54c price target.
08/11/17
08/11/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Strongbridge Biopharma (SBBP) initiated with an Outperform at Oppenheimer. 2. Discovery (DISCA) initiated with a Neutral at Piper Jaffray. 3. MannKind (MNKD) initiated with a Buy at Maxim. 4. Veritone (VERI) initiated with a Buy at Roth Capital. 5. Esperion (ESPR) initiated with a Neutral at BofA/Merrill. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

TWTR

Twitter

$17.61

0.03 (0.17%)

07:19
09/25/17
09/25
07:19
09/25/17
07:19
Periodicals
Twitter tests Twitter Lite Android app in the Philippines, TechCrunch says »

Twitter is testing an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NBLX

Noble Midstream

$50.36

-0.13 (-0.26%)

, NBL

Noble Energy

$27.02

0.07 (0.26%)

07:18
09/25/17
09/25
07:18
09/25/17
07:18
Hot Stocks
Noble Midstream now sees Q3 net income $42M-$43M »

Noble Midstream Partners…

NBLX

Noble Midstream

$50.36

-0.13 (-0.26%)

NBL

Noble Energy

$27.02

0.07 (0.26%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 27

    Sep

  • 03

    Oct

  • 31

    Oct

NOC

Northrop Grumman

$281.55

1.13 (0.40%)

07:17
09/25/17
09/25
07:17
09/25/17
07:17
Hot Stocks
Northrop Grumman announces support contract for U.K. CUTLASS vehicles »

Northrop Grumman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WBC

Wabco

$150.14

0.95 (0.64%)

07:17
09/25/17
09/25
07:17
09/25/17
07:17
Recommendations
Wabco analyst commentary  »

Wabco price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Oct

CSIQ

Canadian Solar

$16.46

0.6 (3.78%)

07:16
09/25/17
09/25
07:16
09/25/17
07:16
Hot Stocks
Tokyo Stock Exchange approves listing of Canadian Solar Infrastructure Fund »

Canadian Solar announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMX

CarMax

$74.19

5.35 (7.77%)

07:16
09/25/17
09/25
07:16
09/25/17
07:16
Downgrade
CarMax rating change  »

CarMax downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALXN

Alexion

$142.82

-0.1 (-0.07%)

07:16
09/25/17
09/25
07:16
09/25/17
07:16
Recommendations
Alexion analyst commentary  »

Alexion Soliris to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

  • 23

    Oct

SGYP

Synergy Pharmaceuticals

$2.59

-0.05 (-1.89%)

07:15
09/25/17
09/25
07:15
09/25/17
07:15
Recommendations
Synergy Pharmaceuticals analyst commentary  »

Synergy Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 24

    Jan

OB

Onebeacon Insurance

$18.11

0.01 (0.06%)

07:14
09/25/17
09/25
07:14
09/25/17
07:14
Hot Stocks
All regulatory approvals obtained for Intact Financial's acquisition of Onebeacon Insurance »

OneBeacon Insurance Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XHR

Xenia Hotels & Resorts

$20.85

0.25 (1.21%)

07:13
09/25/17
09/25
07:13
09/25/17
07:13
Hot Stocks
Xenia Hotels & Resorts provides update on Hyatt Centric Key West Resort & Spa »

Xenia Hotels &…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

AMZN

Amazon.com

$955.10

-9.55 (-0.99%)

, BABA

Alibaba

$178.14

0.75 (0.42%)

07:13
09/25/17
09/25
07:13
09/25/17
07:13
Periodicals
Amazon launches Kindle promotion with Alibaba, Recode reports »

Amazon (AMZN) launched a…

AMZN

Amazon.com

$955.10

-9.55 (-0.99%)

BABA

Alibaba

$178.14

0.75 (0.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

CL

Colgate-Palmolive

$71.19

-0.18 (-0.25%)

07:13
09/25/17
09/25
07:13
09/25/17
07:13
Upgrade
Colgate-Palmolive rating change  »

Colgate-Palmolive…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALB

Albemarle

$134.29

-0.6 (-0.44%)

07:12
09/25/17
09/25
07:12
09/25/17
07:12
Downgrade
Albemarle rating change  »

Albemarle downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

ADNT

Adient

$82.95

0.71 (0.86%)

07:12
09/25/17
09/25
07:12
09/25/17
07:12
Hot Stocks
Adient sees Futuris Group acquisition adding about $500M in annual revenue »

Adient announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BVN

Buenaventura

$12.84

0.09 (0.71%)

07:12
09/25/17
09/25
07:12
09/25/17
07:12
Upgrade
Buenaventura rating change  »

Buenaventura upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVB

AvalonBay

07:12
09/25/17
09/25
07:12
09/25/17
07:12
Upgrade
AvalonBay rating change  »

AvalonBay upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ESS

Essex Property Trust

$255.00

-0.27 (-0.11%)

07:12
09/25/17
09/25
07:12
09/25/17
07:12
Upgrade
Essex Property Trust rating change  »

Essex Property Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HCP

HCP

$27.87

-0.7 (-2.45%)

07:12
09/25/17
09/25
07:12
09/25/17
07:12
Upgrade
HCP rating change  »

HCP upgraded to In Line…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PLD

Prologis

$63.68

-0.68 (-1.06%)

07:11
09/25/17
09/25
07:11
09/25/17
07:11
Downgrade
Prologis rating change  »

Prologis downgraded to In…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BGG

Briggs & Stratton

$22.69

0.29 (1.29%)

07:11
09/25/17
09/25
07:11
09/25/17
07:11
Conference/Events
Briggs & Stratton management to meet with Sidoti »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

ICPT

Intercept

$61.59

-12.11 (-16.43%)

07:11
09/25/17
09/25
07:11
09/25/17
07:11
Hot Stocks
Intercept issues statement regarding Ocaliva safety, dosing in PBC patients »

Intercept Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TUES

Tuesday Morning

07:11
09/25/17
09/25
07:11
09/25/17
07:11
Hot Stocks
Tuesday Morning confirms director nominations from Jeereddi »

Tuesday Morning confirmed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Sep

AMAT

Applied Materials

$47.77

0.62 (1.32%)

07:10
09/25/17
09/25
07:10
09/25/17
07:10
Recommendations
Applied Materials analyst commentary  »

Applied Materials likely…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

IPCI

Intellipharmaceutics

$0.85

-0.0478 (-5.31%)

07:09
09/25/17
09/25
07:09
09/25/17
07:09
Hot Stocks
Intellipharmaceutics receives CRL from FDA for Rexista NDA »

Intellipharmaceutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

PDLI

PDL BioPharma

$3.17

-0.1 (-3.06%)

07:09
09/25/17
09/25
07:09
09/25/17
07:09
Hot Stocks
PDL BioPharma announces $25M stock repurchase program »

PDL BioPharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.